172 related articles for article (PubMed ID: 14592832)
1. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.
Montesinos-Rongen M; Van Roost D; Schaller C; Wiestler OD; Deckert M
Blood; 2004 Mar; 103(5):1869-75. PubMed ID: 14592832
[TBL] [Abstract][Full Text] [Related]
2. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.
Gaidano G; Pasqualucci L; Capello D; Berra E; Deambrogi C; Rossi D; Maria Larocca L; Gloghini A; Carbone A; Dalla-Favera R
Blood; 2003 Sep; 102(5):1833-41. PubMed ID: 12714522
[TBL] [Abstract][Full Text] [Related]
3. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
Pasqualucci L; Neumeister P; Goossens T; Nanjangud G; Chaganti RS; Küppers R; Dalla-Favera R
Nature; 2001 Jul; 412(6844):341-6. PubMed ID: 11460166
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
Deutsch AJ; Frühwirth M; Aigelsreiter A; Cerroni L; Neumeister P
J Invest Dermatol; 2009 Feb; 129(2):476-9. PubMed ID: 18704108
[TBL] [Abstract][Full Text] [Related]
5. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection.
Libra M; Capello D; Gloghini A; Laura P; Berra E; Cerri M; Gasparotto D; Franca S; De Re V; Gaidano G; Carbone A
J Pathol; 2005 May; 206(1):87-91. PubMed ID: 15809970
[TBL] [Abstract][Full Text] [Related]
6. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.
Liso A; Capello D; Marafioti T; Tiacci E; Cerri M; Distler V; Paulli M; Carbone A; Delsol G; Campo E; Pileri S; Pasqualucci L; Gaidano G; Falini B
Blood; 2006 Aug; 108(3):1013-20. PubMed ID: 16614247
[TBL] [Abstract][Full Text] [Related]
7. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma.
Bödör C; Bognár A; Reiniger L; Szepesi A; Tóth E; Kopper L; Matolcsy A
Br J Haematol; 2005 May; 129(3):373-6. PubMed ID: 15842661
[TBL] [Abstract][Full Text] [Related]
8. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Deutsch AJ; Aigelsreiter A; Staber PB; Beham A; Linkesch W; Guelly C; Brezinschek RI; Fruhwirth M; Emberger W; Buettner M; Beham-Schmid C; Neumeister P
Blood; 2007 Apr; 109(8):3500-4. PubMed ID: 17197434
[TBL] [Abstract][Full Text] [Related]
9. Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.
Traverse-Glehen A; Verney A; Baseggio L; Felman P; Callet-Bauchu E; Thieblemont C; Ffrench M; Magaud JP; Coiffier B; Berger F; Salles G
Leukemia; 2007 Aug; 21(8):1821-4. PubMed ID: 17476282
[No Abstract] [Full Text] [Related]
10. Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.
Hiraga J; Katsumi A; Iwasaki T; Abe A; Kiyoi H; Matsushita T; Kinoshita T; Naoe T
Leukemia; 2007 Aug; 21(8):1846-7. PubMed ID: 17443219
[No Abstract] [Full Text] [Related]
11. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
12. Mutations within the 5' region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma.
Scholl V; Stefanoff CG; Hassan R; Spector N; Renault IZ
Leuk Lymphoma; 2007 May; 48(5):957-63. PubMed ID: 17487740
[TBL] [Abstract][Full Text] [Related]
13. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphomas express Vh genes with intermediate to high somatic mutations.
Sekita T; Tamaru JI; Kaito K; Katayama T; Kobayashi M; Mikata A
Leuk Lymphoma; 2001 Apr; 41(3-4):377-85. PubMed ID: 11378551
[TBL] [Abstract][Full Text] [Related]
15. Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.
Cambruzzi E
World Neurosurg; 2020 Feb; 134():215-220. PubMed ID: 31605845
[TBL] [Abstract][Full Text] [Related]
16. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.
Rossi D; Berra E; Cerri M; Deambrogi C; Barbieri C; Franceschetti S; Lunghi M; Conconi A; Paulli M; Matolcsy A; Pasqualucci L; Capello D; Gaidano G
Haematologica; 2006 Oct; 91(10):1405-9. PubMed ID: 17018394
[TBL] [Abstract][Full Text] [Related]
17. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma.
Wohlfart S; Sebinger D; Gruber P; Buch J; Polgar D; Krupitza G; Rosner M; Hengstschläger M; Raderer M; Chott A; Müllauer L
Am J Pathol; 2004 Mar; 164(3):1081-9. PubMed ID: 14982861
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.
Dijkman R; Tensen CP; Buettner M; Niedobitek G; Willemze R; Vermeer MH
Blood; 2006 Jun; 107(12):4926-9. PubMed ID: 16507780
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin repertoire of primary lymphomas of the central nervous system.
Montesinos-Rongen M; Purschke F; Küppers R; Deckert M
J Neuropathol Exp Neurol; 2014 Dec; 73(12):1116-25. PubMed ID: 25383641
[TBL] [Abstract][Full Text] [Related]
20. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
